Business Description
Medlab Clinical Ltd
ISIN : AU000000MDC8
Compare
Compare
Traded in other countries / regions
MDC.AustraliaMDBBF.USA IPO Date
2017-11-21Description
Medlab Clinical Ltd is a medical research and development company. It is engaged in researching and formulating novel biotherapeutics to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease, pre-diabetes, and obesity. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.28 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 0.64 | |||||
| Debt-to-EBITDA | -0.14 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -30.37 | |||||
| Beneish M-Score | -10.51 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -40.9 | |||||
| 3-Year EBITDA Growth Rate | 32.6 | |||||
| 3-Year EPS without NRI Growth Rate | 30.7 | |||||
| 3-Year FCF Growth Rate | 30.3 | |||||
| 3-Year Book Growth Rate | -55.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.67 | |||||
| Quick Ratio | 1.67 | |||||
| Cash Ratio | 0.12 | |||||
| Days Inventory | 277.81 | |||||
| Days Sales Outstanding | 310.44 | |||||
| Days Payable | 4976.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.4 | |||||
| Shareholder Yield % | 2.59 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 89.91 | |||||
| Operating Margin % | -1107.96 | |||||
| Net Margin % | -759.87 | |||||
| FCF Margin % | -614.14 | |||||
| ROE % | -161.19 | |||||
| ROA % | -96.84 | |||||
| ROIC % | -340.6 | |||||
| ROC (Joel Greenblatt) % | -470.94 | |||||
| ROCE % | -147.69 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 16.88 | |||||
| PB Ratio | 11.76 | |||||
| Price-to-Tangible-Book | 11.76 | |||||
| EV-to-EBIT | -1.71 | |||||
| EV-to-EBITDA | -1.92 | |||||
| EV-to-Forward-EBITDA | -1.66 | |||||
| EV-to-Revenue | 12.34 | |||||
| EV-to-Forward-Revenue | 1.59 | |||||
| EV-to-FCF | -2.01 | |||||
| Price-to-Net-Current-Asset-Value | 12.22 | |||||
| Earnings Yield (Greenblatt) % | -58.48 | |||||
| FCF Yield % | -36.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MDBBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medlab Clinical Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.601 | ||
| EPS (TTM) ($) | -2.001 | ||
| Beta | -0.1 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 15.75 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 15.75 - 15.75 | ||
| Shares Outstanding (Mil) | 2.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medlab Clinical Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medlab Clinical Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medlab Clinical Ltd Frequently Asked Questions
What is Medlab Clinical Ltd(MDBBF)'s stock price today?
The current price of MDBBF is $15.75. The 52 week high of MDBBF is $15.75 and 52 week low is $15.75.
When is next earnings date of Medlab Clinical Ltd(MDBBF)?
The next earnings date of Medlab Clinical Ltd(MDBBF) is .
Does Medlab Clinical Ltd(MDBBF) pay dividends? If so, how much?
Medlab Clinical Ltd(MDBBF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers